OPKO Health Cash on Hand 2010-2024 | OPK

OPKO Health cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
OPKO Health Annual Cash on Hand
(Millions of US $)
2023 $96
2022 $153
2021 $135
2020 $72
2019 $85
2018 $96
2017 $91
2016 $169
2015 $194
2014 $97
2013 $186
2012 $27
2011 $72
2010 $18
2009 $43
OPKO Health Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $41
2024-03-31 $76
2023-12-31 $96
2023-09-30 $139
2023-06-30 $108
2023-03-31 $111
2022-12-31 $153
2022-09-30 $181
2022-06-30 $210
2022-03-31 $102
2021-12-31 $135
2021-09-30 $149
2021-06-30 $66
2021-03-31 $90
2020-12-31 $72
2020-09-30 $36
2020-06-30 $22
2020-03-31 $35
2019-12-31 $85
2019-09-30 $65
2019-06-30 $111
2019-03-31 $207
2018-12-31 $96
2018-09-30 $44
2018-06-30 $80
2018-03-31 $100
2017-12-31 $91
2017-09-30 $100
2017-06-30 $131
2017-03-31 $131
2016-12-31 $169
2016-09-30 $145
2016-06-30 $172
2016-03-31 $175
2015-12-31 $194
2015-09-30 $212
2015-06-30 $221
2015-03-31 $348
2014-12-31 $97
2014-09-30 $118
2014-06-30 $134
2014-03-31 $156
2013-12-31 $186
2013-09-30 $181
2013-06-30 $169
2013-03-31 $182
2012-12-31 $27
2012-09-30 $42
2012-06-30 $55
2012-03-31 $62
2011-12-31 $72
2011-09-30 $87
2011-06-30 $94
2011-03-31 $108
2010-12-31 $18
2010-09-30 $15
2010-06-30 $20
2010-03-31 $39
2009-12-31 $43
2009-09-30 $63
2009-06-30 $41
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.039B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $228.667B 27.41
Intuitive Surgical (ISRG) United States $171.263B 96.97
Alcon (ALC) Switzerland $47.978B 33.77
IQVIA Holdings (IQV) United States $41.900B 23.74
Edwards Lifesciences (EW) United States $39.451B 25.29
IDEXX Laboratories (IDXX) United States $39.315B 47.29
DexCom (DXCM) United States $27.294B 38.92
STERIS (STE) Ireland $22.783B 26.58
SONOVA HOLDING (SONVY) Switzerland $21.950B 0.00
Waters (WAT) United States $20.926B 31.20
Hologic (HOLX) United States $18.638B 20.26
Sysmex ADR (SSMXY) Japan $12.525B 39.28
Fresenius Medical Care AG KGaA (FMS) Germany $12.147B 13.62
Teleflex (TFX) United States $11.269B 17.52
Globus Medical (GMED) United States $9.568B 26.77
Penumbra (PEN) United States $7.564B 78.52
Masimo (MASI) United States $7.385B 39.55
Glaukos (GKOS) United States $7.197B 0.00
TransMedics (TMDX) United States $4.636B 198.53
Integer Holdings (ITGR) United States $4.329B 25.32
PROCEPT BioRobotics (PRCT) United States $3.773B 0.00
LivaNova (LIVN) United Kingdom $2.923B 17.14
Tandem Diabetes Care (TNDM) United States $2.735B 0.00
Nihon Kohden (NHNKY) Japan $2.599B 16.17
Elekta AB (EKTAY) Sweden $2.596B 21.15
Veracyte (VCYT) United States $2.523B 156.38
Inari Medical (NARI) United States $2.443B 0.00
RxSight (RXST) United States $1.809B 0.00
Integra LifeSciences Holdings (IART) United States $1.319B 6.01
Artivion (AORT) United States $1.108B 101.69
AVANOS MEDICAL, INC (AVNS) United States $1.066B 19.02
Pulse Biosciences (PLSE) United States $0.979B 0.00
Alphatec Holdings (ATEC) United States $0.771B 0.00
Mesa Laboratories (MLAB) United States $0.723B 18.25
IRadimed (IRMD) United States $0.631B 34.12
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.612B 0.00
AxoGen (AXGN) United States $0.599B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.584B 0.00
Paragon 28 (FNA) United States $0.491B 0.00
Pacific Biosciences Of California (PACB) United States $0.469B 0.00
Tactile Systems Technology (TCMD) United States $0.343B 10.47
Treace Medical Concepts (TMCI) United States $0.332B 0.00
ClearPoint Neuro (CLPT) United States $0.309B 0.00
Sight Sciences (SGHT) United States $0.292B 0.00
AngioDynamics (ANGO) United States $0.248B 0.00
Delcath Systems (DCTH) United States $0.244B 0.00
Inogen (INGN) United States $0.216B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.192B 0.00
CVRx (CVRX) United States $0.191B 0.00
Nevro (NVRO) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.185B 0.00
Semler Scientific (SMLR) United States $0.175B 12.25
Alpha Tau Medical (DRTS) Israel $0.159B 0.00
908 Devices (MASS) United States $0.121B 0.00
KORU Medical Systems (KRMD) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.119B 0.00
Sensus Healthcare (SRTS) United States $0.103B 15.34
EDAP TMS S.A (EDAP) France $0.098B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
WORK Medical Technology Group (WOK) China $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
Envoy Medical (COCH) United States $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.063B 0.00
LENSAR (LNSR) United States $0.052B 0.00
Accelerate Diagnostics (AXDX) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.044B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
T2 Biosystems (TTOO) United States $0.032B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Pixie Dust Technologies (PXDT) Japan $0.028B 0.00
Neuronetics (STIM) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Spectral AI (MDAI) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Autonomix Medical (AMIX) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
PAVmed (PAVM) United States $0.013B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00